Clinical Trial Update: Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial by ImmunityBio for relapsed/refractory B-cell non-Hodgkin lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Relapsed B-Cell Non Hodgkin Lymphoma | Phase 2 | Status: RECRUITING